Wednesday, September 15, 2021

Enzene gets DCGI nod for biosimilar drug to treat haematological disorder - The Financial Express

... by Amgen in 2008 and it is a biologic drug which is developed by the complex genetic engineering process of recombinant DNA technology.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...